Yamagishi Hiroyuki, Maeda Jun, Uchida Keiko, Tsuchihashi Takatoshi, Nakazawa Maki, Aramaki Megumi, Kodo Kazuki, Yamagishi Chihiro
Department of Pediatrics, Division of Pediatric Cardiology, Keio University School of Medicine, Tokyo, Japan.
Anat Sci Int. 2009 Sep;84(3):88-94. doi: 10.1007/s12565-009-0023-4. Epub 2009 Apr 7.
Congenital heart diseases (CHD) result from abnormal morphogenesis of the embryonic cardiovascular system and usually involve defects in specific structural components of the developing heart and vessels. Therefore, an understanding of "Molecular Embryology", with specific focus on the individual modular steps involved in cardiovascular morphogenesis, is particularly relevant to those wishing to have a better insight into the origin of CHD. Recent advances in molecular embryology suggest that the cardiovascular system arises from multiple distinct embryonic origins, and a population of myocardial precursor cells in the pharyngeal mesoderm anterior to the early heart tube, denoted the "second heart field", has been identified. Discovery of the second heart field has important implications for the interpretation of cardiac outflow tract development and provides new insights into the morphogenesis of CHD.
先天性心脏病(CHD)源于胚胎心血管系统的异常形态发生,通常涉及发育中心脏和血管特定结构成分的缺陷。因此,了解“分子胚胎学”,特别是关注心血管形态发生中涉及的各个模块化步骤,对于那些希望更好地洞察先天性心脏病起源的人来说尤为重要。分子胚胎学的最新进展表明,心血管系统起源于多个不同的胚胎来源,并且已经确定了早期心脏管前方咽中胚层中的一群心肌前体细胞,称为“第二心脏场”。第二心脏场的发现对心脏流出道发育的解释具有重要意义,并为先天性心脏病的形态发生提供了新的见解。